IL149208A0 - Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophlaxis of disease states as result of ischaemic conditions - Google Patents

Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophlaxis of disease states as result of ischaemic conditions

Info

Publication number
IL149208A0
IL149208A0 IL14920800A IL14920800A IL149208A0 IL 149208 A0 IL149208 A0 IL 149208A0 IL 14920800 A IL14920800 A IL 14920800A IL 14920800 A IL14920800 A IL 14920800A IL 149208 A0 IL149208 A0 IL 149208A0
Authority
IL
Israel
Prior art keywords
prophlaxis
medicament
treatment
production
result
Prior art date
Application number
IL14920800A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL149208A0 publication Critical patent/IL149208A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14920800A 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophlaxis of disease states as result of ischaemic conditions IL149208A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
IL149208A0 true IL149208A0 (en) 2002-11-10

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14920800A IL149208A0 (en) 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophlaxis of disease states as result of ischaemic conditions

Country Status (30)

Country Link
US (1) US6291502B1 (ru)
EP (1) EP1227811B1 (ru)
JP (1) JP2003512419A (ru)
KR (1) KR20020060213A (ru)
CN (1) CN1188125C (ru)
AR (1) AR026241A1 (ru)
AT (1) ATE257702T1 (ru)
AU (1) AU778836B2 (ru)
BR (1) BR0015024A (ru)
CA (1) CA2388956A1 (ru)
CZ (1) CZ295925B6 (ru)
DE (2) DE19951701A1 (ru)
DK (1) DK1227811T3 (ru)
EE (1) EE200200218A (ru)
ES (1) ES2213621T3 (ru)
HK (1) HK1048938B (ru)
HR (1) HRP20020362A2 (ru)
HU (1) HUP0203213A3 (ru)
IL (1) IL149208A0 (ru)
NO (1) NO20021909L (ru)
NZ (1) NZ518586A (ru)
PL (1) PL355911A1 (ru)
PT (1) PT1227811E (ru)
RU (1) RU2257205C2 (ru)
SK (1) SK5512002A3 (ru)
TR (1) TR200201140T2 (ru)
TW (1) TWI246424B (ru)
WO (1) WO2001030327A2 (ru)
YU (1) YU20902A (ru)
ZA (1) ZA200203035B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1911740B1 (en) * 2002-01-04 2013-02-27 NeuroSearch A/S Potassium channel modulators
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
CA2258165C (en) 1996-06-27 2009-03-03 Marc Gaston Venet N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Also Published As

Publication number Publication date
AU778836B2 (en) 2004-12-23
YU20902A (sh) 2004-11-25
AR026241A1 (es) 2003-02-05
PL355911A1 (en) 2004-05-31
ATE257702T1 (de) 2004-01-15
BR0015024A (pt) 2002-06-18
HK1048938A1 (en) 2003-04-25
CZ20021452A3 (cs) 2002-07-17
JP2003512419A (ja) 2003-04-02
ES2213621T3 (es) 2004-09-01
CN1188125C (zh) 2005-02-09
WO2001030327A3 (de) 2002-03-14
DE50005040D1 (de) 2004-02-19
HRP20020362A2 (en) 2004-02-29
RU2257205C2 (ru) 2005-07-27
DE19951701A1 (de) 2001-05-03
SK5512002A3 (en) 2002-08-06
EP1227811A2 (de) 2002-08-07
US6291502B1 (en) 2001-09-18
NO20021909D0 (no) 2002-04-23
TWI246424B (en) 2006-01-01
ZA200203035B (en) 2003-03-14
NZ518586A (en) 2004-07-30
KR20020060213A (ko) 2002-07-16
DK1227811T3 (da) 2004-04-19
NO20021909L (no) 2002-04-23
HUP0203213A3 (en) 2003-07-28
AU1138201A (en) 2001-05-08
CA2388956A1 (en) 2001-05-03
CZ295925B6 (cs) 2005-11-16
CN1373663A (zh) 2002-10-09
TR200201140T2 (tr) 2002-11-21
WO2001030327A2 (de) 2001-05-03
HK1048938B (zh) 2005-06-10
EE200200218A (et) 2003-06-16
HUP0203213A2 (en) 2003-05-28
PT1227811E (pt) 2004-05-31
EP1227811B1 (de) 2004-01-14
RU2002113666A (ru) 2004-01-10

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL153214A0 (en) Compounds to treat alzheimer's disease
AU2001273132A1 (en) Compounds to treat alzheimer's disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL173145A (en) Use of a pak inhibitor for the production of a medicament for the treatment of a joint disease
HK1087025A1 (en) Use of immunomudulatory compounds in preparation of a medicament for treating, preventing or managing myeloproliferative diseases
HK1080361A1 (en) The use of compound in the preparation of medicaments for treating demyelinating diseases
GB0023915D0 (en) Treatment of neuroinflammatory disease
GB0004531D0 (en) The treatment of respiratory diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2002231811A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
IL149208A0 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophlaxis of disease states as result of ischaemic conditions
AU2003284898A1 (en) Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease
SI1227811T1 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
AU2001254712A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
PL356399A1 (en) Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
GB0306088D0 (en) Process for the preparation of a cosmetic active
IL150122A0 (en) Remedies for external use for allergic skin diseases
GB0209254D0 (en) Preparation for the relief of disease
GB0314531D0 (en) Process for the preparation of a cosmetic active
PL367634A1 (en) Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
EP1426762A4 (en) DRUGS FOR CARDIAC DISEASES
HUP0302653A3 (en) A method for the treatment of plant diseases by the application of pseudomycins